BIT-225

N/A

Report date: 2022/03/17 09:53:50
NME

Base Information

Drug NameBIT-225
Drug Alias NameBIT-225
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCapsid protein inhibitors
TargetsCapsid protein
Therapy Area/IndicationsHepatitis CHIV Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesBiotron
China Registration ClassN/A

Develop Information

Active CompaniesBiotron
Inactive CompaniesN/A
Active IndicationsHepatitis CHIV Infections
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksWikipedia